164 related articles for article (PubMed ID: 9687443)
1. One hundred seventy-fold increase in excretion of an FV fragment-tumor necrosis factor alpha fusion protein (sFV/TNF-alpha) from Escherichia coli caused by the synergistic effects of glycine and triton X-100.
Yang J; Moyana T; MacKenzie S; Xia Q; Xiang J
Appl Environ Microbiol; 1998 Aug; 64(8):2869-74. PubMed ID: 9687443
[TBL] [Abstract][Full Text] [Related]
2. An efficient protocol to enhance the extracellular production of recombinant protein from Escherichia coli by the synergistic effects of sucrose, glycine, and Triton X-100.
Bao RM; Yang HM; Yu CM; Zhang WF; Tang JB
Protein Expr Purif; 2016 Oct; 126():9-15. PubMed ID: 27189822
[TBL] [Abstract][Full Text] [Related]
3. Improved expression of a soluble single chain antibody fusion protein containing tumor necrosis factor in Escherichia coli.
Kim S; Cheung LH; Zhang W; Rosenblum MG
Appl Microbiol Biotechnol; 2007 Nov; 77(1):99-106. PubMed ID: 17703297
[TBL] [Abstract][Full Text] [Related]
4. Substitution of surface-exposed framework residues alters secretion of recombinant fusion protein Fv/tumor necrosis factor in Escherichia coli.
Yang J; Jia Z; Xiang J
IUBMB Life; 1999 Sep; 48(3):327-32. PubMed ID: 10690647
[TBL] [Abstract][Full Text] [Related]
5. Secretion of recombinant archeal lipase mediated by SVP2 signal peptide in Escherichia coli and its optimization by response surface methodology.
Pournejati R; Karbalaei-Heidari HR; Budisa N
Protein Expr Purif; 2014 Sep; 101():84-90. PubMed ID: 24907409
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
[TBL] [Abstract][Full Text] [Related]
7. A genetically engineered single-chain FV/TNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor.
Yang J; Moyana T; Xiang J
Mol Immunol; 1995 Aug; 32(12):873-81. PubMed ID: 7565814
[TBL] [Abstract][Full Text] [Related]
8. The effects of induction conditions on production of a soluble anti-tumor sFv in Escherichia coli.
Sawyer JR; Schlom J; Kashmiri SV
Protein Eng; 1994 Nov; 7(11):1401-6. PubMed ID: 7700873
[TBL] [Abstract][Full Text] [Related]
9. In vivo tumor delivery of a recombinant single chain Fv::tumor necrosis factor-alpha fusion [correction of factor: a fusion] protein.
Cooke SP; Pedley RB; Boden R; Begent RH; Chester KA
Bioconjug Chem; 2002; 13(1):7-15. PubMed ID: 11792173
[TBL] [Abstract][Full Text] [Related]
10. Optimization of TNF-α overexpression in Escherichia coli using response surface methodology: Purification of the protein and oligomerization studies.
Papaneophytou CP; Kontopidis GA
Protein Expr Purif; 2012 Nov; 86(1):35-44. PubMed ID: 22989548
[TBL] [Abstract][Full Text] [Related]
11. [Construction and expression of hTNF-alpha fusion protein mediated by MMP1].
Zhao Q; Hou G; Huang D; Chen S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Jun; 28(3):534-7. PubMed ID: 21774218
[TBL] [Abstract][Full Text] [Related]
12. Construction and high-level expression of a single-chain Fv antibody fragment specific for acidic isoferritin in Escherichia coli.
Guo JQ; You SY; Li L; Zhang YZ; Huang JN; Zhang CY
J Biotechnol; 2003 Apr; 102(2):177-89. PubMed ID: 12697395
[TBL] [Abstract][Full Text] [Related]
13. Expression of recombinant feline tumor necrosis factor is toxic to Escherichia coli.
Otto CM; Niagro F; Su X; Rawlings CA
Clin Diagn Lab Immunol; 1995 Nov; 2(6):740-6. PubMed ID: 8574840
[TBL] [Abstract][Full Text] [Related]
14. Expression and Secretion of Endostar Protein by Escherichia Coli: Optimization of Culture Conditions Using the Response Surface Methodology.
Mohajeri A; Abdolalizadeh J; Pilehvar-Soltanahmadi Y; Kiafar F; Zarghami N
Mol Biotechnol; 2016 Oct; 58(10):634-647. PubMed ID: 27377615
[TBL] [Abstract][Full Text] [Related]
15. Recombinant expression, purification and bioactivity characterization of extracellular domain of human tumor necrosis factor receptor 1.
Zhang C; Li A; Wang R; Cao Y; Jiang H; Ouyang S; Ma X; Lu Y
Protein Expr Purif; 2019 Mar; 155():21-26. PubMed ID: 30414969
[TBL] [Abstract][Full Text] [Related]
16. Optimization of culture conditions for high-level expression of soluble and active tumor necrosis factor-α in E. coli.
Damough S; Sabzalinezhad M; Talebkhan Y; Nematollahi L; Bayat E; Torkashvand F; Adeli A; Jahandar H; Barkhordari F; Mahboudi F
Protein Expr Purif; 2021 Mar; 179():105805. PubMed ID: 33290843
[TBL] [Abstract][Full Text] [Related]
17. Excretion of human beta-endorphin into culture medium by using outer membrane protein F as a fusion partner in recombinant Escherichia coli.
Jeong KJ; Lee SY
Appl Environ Microbiol; 2002 Oct; 68(10):4979-85. PubMed ID: 12324347
[TBL] [Abstract][Full Text] [Related]
18. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
Schultz J; Lin Y; Sanderson J; Zuo Y; Stone D; Mallett R; Wilbert S; Axworthy D
Cancer Res; 2000 Dec; 60(23):6663-9. PubMed ID: 11118050
[TBL] [Abstract][Full Text] [Related]
19. High-level expression of cecropin CMIV in E. coli from a fusion construct containing the human tumor necrosis factor.
Wang L; Wu H; Dou F; Xie W; Xu X
Biochem Mol Biol Int; 1997 Apr; 41(5):1051-6. PubMed ID: 9137837
[TBL] [Abstract][Full Text] [Related]
20. Study on improvement of extracellular production of recombinant Thermobifida fusca cutinase by Escherichia coli.
Chen S; Liu Z; Chen J; Wu J
Appl Biochem Biotechnol; 2011 Sep; 165(2):666-75. PubMed ID: 21594592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
